InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

20 October 2025

Name:

PROBIOMICS LIMITED (PCC)
(This company subsequently changed its name to BIOXYNE LIMITED. You should refer to that name for Status.)

Date of Listing:

14 December 2000

Subsequent Names:

Company Name	Start Date	End Date
BIOXYNE LIMITED	10/04/2012

Former Names:

Stock Exchange Status: (updated daily)

This company subsequently changed its name to BIOXYNE LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

This company subsequently changed its name to BIOXYNE LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now BIOXYNE LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

PROBIOMICS LIMITED(PCC)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
BIOXYNE LIMITED	10/04/2012
PROBIOMICS LIMITED	02/05/2005	10/04/2012
VRI BIOMEDICAL LIMITED		02/05/2005

Shareholder links

REGISTRY:

Level 4, 44 Martin Place Sydney NSW 2000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: Suite 1A, Level 2, 802 Pacific Highway, GORDON, NSW, AUSTRALIA, 2072
Tel: (02) 9844 5422 Fax: (02) 9844 5445

Date first listed: 14/12/2000
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Commercialisation and further development of probiotic technology, with its lead probiotic, PCC, a novel strain of Lactobacillus fermentum

News & Events

Expand this box to read and print

name changed to Bioxyne Limited	10/04/2012
The suspension of trading in the securities of Probiomics Limited will be lifted from the commencement of trading on Wednesday, 4 April 2012 following re-compliance with Chapters 1 and 2 of the ASX Listing Rules	03/04/2012
we understand that on or about this date the company consolidated its shares 1 for 20	29/03/2012
Probiomics ("Company", ASX: PCC) expects that the re-admission of the Company to the ASX Official List, and the re-commencement of trading in the Company" securities on ASX will occur on 4 April, 2012	15/03/2012
Probiomics Limited ("Company" ASX Code:PCC) advised in its announcement dated 3 February, 2012 that the proposed 1:20 share consolidation would occur on 21 March, 2012. The Company advises that the occurrence of that share consolidation will be slightly delayed and that the Company will be shortly publishing an amended timetable	14/03/2012
Probiomics Limited (ASX: PCC) (Probiomics) announces that the minimum subscription of $2.2 million under the Public Offer has been achieved	02/03/2012
Half Yearly Report And Accounts released	01/03/2012
The securities of Probiomics Limited (the "Company") will be suspended from quotation immediately, following shareholder approval of resolutions at the Company" general meeting regarding the takeover of Hunter Immunology Limited.	07/02/2012
the suspension of trading in the securities of Probiomics Limited (the "Company") will be lifted immediately following receipt of an announcement regarding the Company's proposed merger with Hunter Immunology Limited	12/10/2011
the securities of Probiomics Limited (the "Company") will be suspended from quotation immediately, following the announcement of the Company's proposed merger with Hunter Immunology Limited	11/10/2011
securities reinstated to quotation	04/03/2008
securities suspended from quotation following failure to lodge its half report for the period ended 31 December 2007	03/03/2008
name changed from VRI Biomedical Limited	02/05/2005

OFX Transferring Money Internationally to Free

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Patrick Ford	Non Exec Chairman	20/05/2005
Ashok Jairath	CFO, Company Secretary	27/07/2007
Simon O'Loughlin	Non Exec Director	31/07/2008
Simon Taylor	Non Exec Director	25/07/2008

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.